TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Conformational, Curative Ratiotherapy For Prostate Cancer (NO, N-): Phase III Multicenter Study Of The Contribution To Survival Without Clinical Or Biological Change With A Dose Variation Of 15% (80 Gy VS 70 Gy)
Brief Summary: RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which regimen of radiation therapy is more effective for prostate cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of radiation therapy in treating patients who have localized prostate cancer.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Gray | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Radiation: Gray | Intervention Type: RADIATION; Name: Gray; Assigned to Arm(s): 1 | Intervention Type: RADIATION; Name: Gray; Assigned to Arm(s): 2
B: Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A
C: Arm Label: Radical prostatectomy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Radical prostatectomy | Arm Label: Conformal radiation therapy; Type: ACTIVE_COMPARATOR; Interventions: Radiation: Conformal radiation therapy | Arm Label: Active monitoring; Type: ACTIVE_COMPARATOR; Interventions: Other: Active monitoring | Intervention Type: PROCEDURE; Name: Radical prostatectomy; Assigned to Arm(s): Radical prostatectomy | Intervention Type: RADIATION; Name: Conformal radiation therapy; Assigned to Arm(s): Conformal radiation therapy | Intervention Type: OTHER; Name: Active monitoring; Assigned to Arm(s): Active monitoring
D: Arm Label: Arm I; Type: EXPERIMENTAL; Interventions: Radiation: 3-dimensional conformal radiation therapy, Radiation: intensity-modulated radiation therapy | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Radiation: 3-dimensional conformal radiation therapy, Radiation: intensity-modulated radiation therapy | Intervention Type: RADIATION; Name: 3-dimensional conformal radiation therapy; Assigned to Arm(s): Arm I, Arm II | Intervention Type: RADIATION; Name: intensity-modulated radiation therapy; Assigned to Arm(s): Arm I, Arm II

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acupuncture in the Treatment of Depression
Brief Summary: The current large randomized placebo-controlled trial is testing the ability of acupuncture to treat major depression. The study is unique in that treatment effects will be from the perspective of both Western psychiatry and Chinese medicine.


Options:
A: Arm Label: Behavioral based In-home Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Based In-Home Intervention | Intervention Type: BEHAVIORAL; Name: Behavioral Based In-Home Intervention; Assigned to Arm(s): Behavioral based In-home Intervention
B: Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): N/A
C: Arm Label: NET; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Exposure Therapy | Arm Label: AC; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Academic Counseling | Arm Label: WL; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Narrative Exposure Therapy; Assigned to Arm(s): NET | Intervention Type: BEHAVIORAL; Name: Academic Counseling; Assigned to Arm(s): AC
D: Arm Label: Minimal Contact Control; Type: OTHER; Interventions: Behavioral: Minimal Contact Control | Arm Label: PE-Massed; Type: EXPERIMENTAL; Interventions: Behavioral: Prolonged Exposure Therapy - Massed | Arm Label: PE-Spaced; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prolonged Exposure Therapy - Spaced | Arm Label: Present-Centered Therapy (PCT); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Present-Centered Therapy | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure Therapy - Massed; Assigned to Arm(s): PE-Massed | Intervention Type: BEHAVIORAL; Name: Prolonged Exposure Therapy - Spaced; Assigned to Arm(s): PE-Spaced | Intervention Type: BEHAVIORAL; Name: Minimal Contact Control; Assigned to Arm(s): Minimal Contact Control | Intervention Type: BEHAVIORAL; Name: Present-Centered Therapy; Assigned to Arm(s): Present-Centered Therapy (PCT)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Acupuncture in the Treatment of Depression
Brief Summary: The current large randomized placebo-controlled trial is testing the ability of acupuncture to treat major depression. The study is unique in that treatment effects will be from the perspective of both Western psychiatry and Chinese medicine.


Options:
A: Intervention Type: PROCEDURE; Name: Acupuncture; Assigned to Arm(s): N/A
B: Arm Label: Traditional Acupuncture; Type: EXPERIMENTAL; Interventions: Other: Acupuncture | Arm Label: Minimal Acupuncture; Type: ACTIVE_COMPARATOR; Interventions: Other: Acupuncture | Arm Label: Placebo Acupuncture; Type: PLACEBO_COMPARATOR; Interventions: Other: Acupuncture | Intervention Type: OTHER; Name: Acupuncture; Assigned to Arm(s): Minimal Acupuncture, Placebo Acupuncture, Traditional Acupuncture
C: Arm Label: DCEAS; Type: EXPERIMENTAL; Interventions: Procedure: DCEAS (Hwato®/ Dongbang®), Procedure: Body electro-acupuncture (Hwato®/ Dongbang®), Drug: Fluoxetine | Arm Label: n-CEA; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Body electro-acupuncture (Hwato®/ Dongbang®), Procedure: n-CEA (Strietberger®), Drug: Fluoxetine | Intervention Type: PROCEDURE; Name: DCEAS (Hwato®/ Dongbang®); Assigned to Arm(s): DCEAS | Intervention Type: PROCEDURE; Name: Body electro-acupuncture (Hwato®/ Dongbang®); Assigned to Arm(s): DCEAS, n-CEA | Intervention Type: PROCEDURE; Name: n-CEA (Strietberger®); Assigned to Arm(s): n-CEA | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): DCEAS, n-CEA
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: Electroacupuncture | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Sham | Intervention Type: PROCEDURE; Name: Electroacupuncture; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Sham; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dose-response to Exercise in Women Aged 45-75 Years (DREW)
Brief Summary: To investigate the effects of different amounts of exercise on both cardiorespiratory fitness and risk factors for cardiovascular disease in sedentary, overweight, mildly hypertensive, but healthy, postmenopausal women aged 45 to 75 years.


Options:
A: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Behavioral: specific training program | Arm Label: control; Type: ACTIVE_COMPARATOR; Interventions: Other: standard | Intervention Type: OTHER; Name: standard; Assigned to Arm(s): control | Intervention Type: BEHAVIORAL; Name: specific training program; Assigned to Arm(s): exercise
B: Intervention Type: BEHAVIORAL; Name: Supervised Exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Home-Based Exercise; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Sertraline (Zoloft); Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo Pill; Assigned to Arm(s): N/A
C: Intervention Type: BEHAVIORAL; Name: Endurance training; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Weight-lifting training; Assigned to Arm(s): N/A
D: Arm Label: Non-Exercise Control Group; Type: N/A; Interventions: Behavioral: Exercise | Arm Label: 4-kcal/kg Energy Expenditure per week; Type: N/A; Interventions: Behavioral: Exercise | Arm Label: 8-kcal/kg Energy Expenditure per week; Type: N/A; Interventions: Behavioral: Exercise | Arm Label: 12-kcal/kg Energy Expenditure per week; Type: N/A; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): 12-kcal/kg Energy Expenditure per week, 4-kcal/kg Energy Expenditure per week, 8-kcal/kg Energy Expenditure per week, Non-Exercise Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma
Brief Summary: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.


Options:
A: Intervention Type: DRUG; Name: tiotropium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Doxycycline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Doxycycline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Intervention Type: DRUG; Name: azithromycin (drug); Assigned to Arm(s): N/A
D: Arm Label: Arm I; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel, Drug: Carboplatin | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride | Arm Label: Arm III; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Pegylated Liposomal Doxorubicin Hydrochloride | Arm Label: Arm IV; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Topotecan Hydrochloride | Arm Label: Arm V; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride, Procedure: Therapeutic Conventional Surgery | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Gemcitabine Hydrochloride; Assigned to Arm(s): Arm II, Arm V | Intervention Type: DRUG; Name: Pegylated Liposomal Doxorubicin Hydrochloride; Assigned to Arm(s): Arm III | Intervention Type: DRUG; Name: Topotecan Hydrochloride; Assigned to Arm(s): Arm IV | Intervention Type: PROCEDURE; Name: Therapeutic Conventional Surgery; Assigned to Arm(s): Arm V

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma
Brief Summary: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.


Options:
A: Arm Label: Arm I; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel, Drug: Carboplatin | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride | Arm Label: Arm III; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Pegylated Liposomal Doxorubicin Hydrochloride | Arm Label: Arm IV; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Topotecan Hydrochloride | Arm Label: Arm V; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride, Procedure: Therapeutic Conventional Surgery | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Gemcitabine Hydrochloride; Assigned to Arm(s): Arm II, Arm V | Intervention Type: DRUG; Name: Pegylated Liposomal Doxorubicin Hydrochloride; Assigned to Arm(s): Arm III | Intervention Type: DRUG; Name: Topotecan Hydrochloride; Assigned to Arm(s): Arm IV | Intervention Type: PROCEDURE; Name: Therapeutic Conventional Surgery; Assigned to Arm(s): Arm V
B: Arm Label: Azithromycin; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin 250 mg | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Azithromycin 250 mg; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo
C: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Drug: Avelox (Moxifloxacin, BAY12-8039) | Arm Label: Arm 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Avelox (Moxifloxacin, BAY12-8039); Assigned to Arm(s): Arm 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Arm 2
D: Arm Label: Azithromycin; Type: EXPERIMENTAL; Interventions: Drug: azithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: azithromycin; Assigned to Arm(s): Azithromycin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Randomized Trial Of Paclitaxel And Carboplatin Versus Triplet Or Sequential Doublet Combinations In Patients With Epithelial Ovarian Or Primary Peritoneal Carcinoma
Brief Summary: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is most effective in treating ovarian epithelial cancer and peritoneal cancer. Randomized phase III trial to compare the effectiveness of various combination chemotherapy regimens in treating patients who have stage III or stage IV ovarian cancer or primary peritoneal cancer.


Options:
A: Arm Label: Arm I; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paclitaxel, Drug: Carboplatin | Arm Label: Arm II; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride | Arm Label: Arm III; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Pegylated Liposomal Doxorubicin Hydrochloride | Arm Label: Arm IV; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Topotecan Hydrochloride | Arm Label: Arm V; Type: EXPERIMENTAL; Interventions: Drug: Paclitaxel, Drug: Carboplatin, Drug: Gemcitabine Hydrochloride, Procedure: Therapeutic Conventional Surgery | Intervention Type: DRUG; Name: Paclitaxel; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Carboplatin; Assigned to Arm(s): Arm I, Arm II, Arm III, Arm IV, Arm V | Intervention Type: DRUG; Name: Gemcitabine Hydrochloride; Assigned to Arm(s): Arm II, Arm V | Intervention Type: DRUG; Name: Pegylated Liposomal Doxorubicin Hydrochloride; Assigned to Arm(s): Arm III | Intervention Type: DRUG; Name: Topotecan Hydrochloride; Assigned to Arm(s): Arm IV | Intervention Type: PROCEDURE; Name: Therapeutic Conventional Surgery; Assigned to Arm(s): Arm V
B: Intervention Type: DRUG; Name: Intravenous Clarithromycin; Assigned to Arm(s): N/A
C: Arm Label: Clarithromycin; Type: EXPERIMENTAL; Interventions: Drug: clarithromycin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: clarithromycin | Intervention Type: DRUG; Name: clarithromycin; Assigned to Arm(s): Clarithromycin, Placebo
D: Arm Label: erythromycin; Type: EXPERIMENTAL; Interventions: Drug: Erythromycin | Arm Label: saline; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Erythromycin; Assigned to Arm(s): erythromycin

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Brief Summary: A long-term study of current treatments for bipolar disorder, including medications and psychosocial therapies.


Options:
A: Intervention Type: DRUG; Name: lithium; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: valproate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: bupropion; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: paroxetine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: lamotrigine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: inositol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: tranylcypromine; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Family-focused Therapy; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Interpersonal and Social Rhythms Therapy; Assigned to Arm(s): N/A
B: Arm Label: A Helping Hand (AHH); Type: EXPERIMENTAL; Interventions: Behavioral: Self-care management | Arm Label: Usual Care (UC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-care management; Assigned to Arm(s): A Helping Hand (AHH)
C: Arm Label: Collaborative shared care; Type: EXPERIMENTAL; Interventions: Behavioral: Collaborative shared care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Collaborative shared care | Intervention Type: BEHAVIORAL; Name: Collaborative shared care; Assigned to Arm(s): Collaborative shared care, Usual care
D: Arm Label: Virtual Learning Collaborative; Type: EXPERIMENTAL; Interventions: Other: Virtual Learning Collaborative | Arm Label: Technical Assistance; Type: ACTIVE_COMPARATOR; Interventions: Other: Technical Assistance | Intervention Type: OTHER; Name: Virtual Learning Collaborative; Assigned to Arm(s): Virtual Learning Collaborative | Intervention Type: OTHER; Name: Technical Assistance; Assigned to Arm(s): Technical Assistance

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Immunogenicity of Pneumococcal Conjugate Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Treated With Highly Active Antiretroviral Therapy (HAART)
Brief Summary: The purpose of this study is to determine if 2 doses of Pneumococcal Conjugate Vaccine (PCV) followed by 1 dose of Pneumococcal Polysaccharide Vaccine (PPV) in HIV-infected children on anti-HIV therapy is helpful and safe in fighting pneumococcal infections in this group of children. This study will also look at the protection provided by childhood vaccination against measles, pertussis, and hepatitis B virus.

Pneumococcal infections are the most common AIDS-related infection in HIV-infected children. PCV may help reduce the chances of HIV-infected children getting pneumococcal infections. This study will look at whether pneumococcal vaccines are safe and effective in HIV-infected children receiving HAART. It will look at whether HIV-infected children are protected by childhood vaccines received previously and if more doses are safe and improve protection.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Recombivax | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Biological: Twinrix | Intervention Type: BIOLOGICAL; Name: Recombivax; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Twinrix; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Biological: ALVAC-HIV vCP1521 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Biological: ALVAC HIV-1 vCP1521 | Intervention Type: BIOLOGICAL; Name: ALVAC-HIV vCP1521; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: ALVAC HIV-1 vCP1521; Assigned to Arm(s): 2
C: Intervention Type: BIOLOGICAL; Name: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Measles-Mumps-Rubella Vaccine (Live); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Pneumococcal Vaccine, Polyvalent (23-valent); Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Pneumococcal Conjugate Vaccine, Heptavalent; Assigned to Arm(s): N/A | Intervention Type: BIOLOGICAL; Name: Hepatitis B Vaccine (Recombinant); Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix-B 20 mcg | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Biological: Engerix-B 40 mcg | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Biological: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg | Intervention Type: BIOLOGICAL; Name: Engerix-B 20 mcg; Assigned to Arm(s): 1 | Intervention Type: BIOLOGICAL; Name: Engerix-B 40 mcg; Assigned to Arm(s): 2 | Intervention Type: BIOLOGICAL; Name: Twinrix 720 EIA HAV Ag plus 20 mcg HBsAg; Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparative Effectiveness of Antipsychotic Medications in Patients With Schizophrenia (CATIE Schizophrenia Trial)
Brief Summary: The CATIE Schizophrenia Trial is part of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project. The schizophrenia trial is being conducted to determine the long-term effects and usefulness of antipsychotic medications in persons with schizophrenia. It is designed for people with schizophrenia who may benefit from a medication change. The study involves the newer atypical antipsychotics (olanzapine, quetiapine, risperidone, clozapine, and ziprasidone)and the typical antipsychotics (perphenazine and fluphenazine decanoate). All participants will receive an initial comprehensive medical and psychiatric evaluation and will be closely followed throughout the study. For most participants the study will last up to 18 months. Everyone in the study will be offered an educational program about schizophrenia and family members will be encouraged to participate.


Options:
A: Intervention Type: DRUG; Name: perphenazine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: olanzapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: quetiapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: risperidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: ziprasidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: clozapine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: fluphenazine decanoate; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Ziprasidone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): N/A
C: Arm Label: A1; Type: EXPERIMENTAL; Interventions: Drug: Ziprasidone | Intervention Type: DRUG; Name: Ziprasidone; Assigned to Arm(s): A1
D: Arm Label: Olanzapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, Drug: Quetiapine, Drug: Ziprasidone | Arm Label: Quetiapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, Drug: Risperidone, Drug: Ziprasidone | Arm Label: Risperidone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, Drug: Ziprasidone | Arm Label: Ziprasidone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Olanzapine, Drug: Ziprasidone | Intervention Type: DRUG; Name: Olanzapine; Assigned to Arm(s): Olanzapine, Quetiapine, Risperidone, Ziprasidone | Intervention Type: DRUG; Name: Quetiapine; Assigned to Arm(s): Olanzapine | Intervention Type: DRUG; Name: Risperidone; Assigned to Arm(s): Quetiapine | Intervention Type: DRUG; Name: Ziprasidone; Assigned to Arm(s): Olanzapine, Quetiapine, Risperidone, Ziprasidone

Answer: A